News search
Research 26 Aug 2022 The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM |
Research 9 Aug 2022 A new study published in eLife shows that inhibition of p38γ/δ is a potential therapeutic strategy for the treatment of hypertrophic cardiomyopathy, but that this strategy has yet to be explored because of the lack of specific inhibitors for these p38 family members |
About the CNIC 6 Jul 2022 Through this lifelong honour, new EMBO Members and Associate Members are recognized for their outstanding achievements in the life sciences |
About the CNIC 27 Jan 2022 Five of the past award winners of this award subsequently received the Nobel Prize |
About the CNIC 17 Jun 2021 The jury acknowledged this CNIC researcher's contribution to understanding why obesity causes cardiometabolic diseases. |
About the CNIC 9 Jun 2021 The study, published in Nature in 2019, revealed relevant data about the involvement of the protein p38gamma in the development of the main type of primary liver cancer, which affects over a million people a year worldwide |
Research 7 Jun 2021 A team led by Dr. Jorge Alegre-Cebollada has shown, for the first time, an association between hypertrophic cardiomyopathy and mechanical alterations to a component of the contractile machinery of the heart |
- ‹ previous
- 2 of 8
- next ›